Putnam Investments’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,488
| Closed | -$338K | – | 1201 |
|
|
2022
Q2 | $338K | Buy |
+10,488
| New | +$338K | ﹤0.01% | 1061 |
|
|
2020
Q3 | – | Sell |
-47,983
| Closed | -$2M | – | 890 |
|
|
2020
Q2 | $2M | Buy |
+47,983
| New | +$2M | ﹤0.01% | 678 |
|
|
2018
Q2 | – | Sell |
-9,562
| Closed | -$1.54M | – | 1174 |
|
|
2018
Q1 | $1.54M | Buy |
9,562
+3,579
| +60% | +$576K | ﹤0.01% | 770 |
|
|
2017
Q4 | $986K | Buy |
+5,983
| New | +$986K | ﹤0.01% | 890 |
|
|
2017
Q2 | – | Sell |
-6,995
| Closed | -$497K | – | 1268 |
|
|
2017
Q1 | $497K | Sell |
6,995
-1,629
| -19% | -$116K | ﹤0.01% | 1109 |
|
|
2016
Q4 | $440K | Buy |
8,624
+261
| +3% | +$13.3K | ﹤0.01% | 1139 |
|
|
2016
Q3 | $386K | Sell |
8,363
-11,067
| -57% | -$511K | ﹤0.01% | 1158 |
|
|
2016
Q2 | $586K | Sell |
19,430
-124
| -0.6% | -$3.74K | ﹤0.01% | 1176 |
|
|
2016
Q1 | $627K | Buy |
19,554
+106
| +0.5% | +$3.4K | ﹤0.01% | 1200 |
|
|
2015
Q4 | $1.13M | Sell |
19,448
-358
| -2% | -$20.9K | ﹤0.01% | 1130 |
|
|
2015
Q3 | $838K | Buy |
19,806
+500
| +3% | +$21.2K | ﹤0.01% | 1214 |
|
|
2015
Q2 | $1.41M | Buy |
+19,306
| New | +$1.41M | ﹤0.01% | 1148 |
|